NCT02367339

Brief Summary

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 12, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 20, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

February 20, 2015

Status Verified

February 1, 2015

Enrollment Period

1.2 years

First QC Date

February 12, 2015

Last Update Submit

February 19, 2015

Conditions

Antibiotic ResistanceExtended-spectrum BetalactamaseEnterobacteriaceaeEscherichia Coli

Keywords

Critical CareNursing staffMedical staffExtended-spectrum betalactamaseDigestive tract colonizationCross-contamination

Outcome Measures

Primary Outcomes (1)

  • Digestive tract colonization by ESBL

    Digestive tract colonization by ESBL-producing Enterobacteriaceae on 1 faeces sample

    at day 1

Interventions

ESBLOTHER

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ICU staff

You may qualify if:

  • volunteers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, 63003, France

RECRUITING

MeSH Terms

Conditions

Escherichia coli Infections

Condition Hierarchy (Ancestors)

Enterobacteriaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Study Officials

  • Julien PASCAL

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Patrick LACARIN

CONTACT

04 73 75 11 95placarin@chu-clermontferrand.fr

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2015

First Posted

February 20, 2015

Study Start

February 1, 2015

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

February 20, 2015

Record last verified: 2015-02

Locations

FR(1)